NCT00333814 - A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis | Biotech Hunter

Enrollment

229

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions

Intermediate UveitisPosterior Uveitis

Interventions

DRUG

Dexamethasone

Dexamethasone 350 µg; injection drug delivery system at Day 0

DRUG

dexamethasone

Dexamethasone 700 µg injection drug delivery system at Day 0

DRUG

Sham injection

Sham injection at Day 0

Trial Locations (18)

Dallas

Sydney

Vienna

São Paulo

Montreal

Prague

Paris

Heidelberg

Cholargós

Hyderabad

Petah Tikva

Gdansk

Coimbra

Johannesburg

Seoul

Madrid

Lausanne

London